![]() NodThera NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases driven by chronic inflammation. | ![]() Akero Therapeutics Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ||
Founding Date | Founding Date 2016 | Founding Date 2017 | Founding Date 2016 | Founding Date 1992 |
Type | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Little Chesterford, GB HQ Aberdeen, GB Lexington, US Seattle, US | Locations San Francisco, US HQ Cambridge, US South San Francisco, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Schaumburg, US HQ Gurugram, IN Monthey, CH |
Employees | Employees 234% decrease | Employees 1363% increase | Employees 156% decrease | Employees 1152% increase |
Funding | ||||
Total funding raised | Total funding raised $ 95m | Total funding raised $ 135m | Total funding raised $ 17m | Total funding raised N/A |

Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyIHMA is a company that provides antimicrobial drug development support services.
View company